Congreso Europeo de ISPOR

Spain is undergoing a series of substantial changes in the Health Administration, especially regarding to pharmaceutical policy. The reports on Pharmaceutical Expenditure of the Independent Fiscal Responsibility Authority with regulatory measures that represent an important change in the setting and reimbursement of prices, together with initiatives such as the Valtermed Project to measure the real therapeutic value of new medicines and the appointment of the Pharmaceutical Benefit Advisory Committee, make it essential to know and discuss these initiatives within the Spanish Chapter, which is why the next session is planned for the 2019 congress: